Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility

Phase 3

Completed

• Conditions: Hygiene
• Interventions: Drug: Lactic Acid

• Registration Number: NCT00783861
• Lead Sponsor: Sanofi

Brief Summary

To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Femina (Lactic Acid) Pocket BR.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-10
• Study First Submitted: 2008-10-31
• Study First Submitted QC: 2008-10-31
• Primary Completion: 2008-11
• Study First Posted: 2008-11-02
• Status Verified: 2008-12
• Last Update Submitted: 2008-12-18
• Last Update Posted: 2008-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 54

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Lactic Acid	Lactic Acid (Dermacyd Femina)

Primary Outcome Measures

Name	Time	Method
The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.	Throughout the study

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office; 🇧🇷 Sao Paulo, Brazil